The regulatory effects of thyroid hormone on biosynthesis of myocardial proteins that originate from cardiac myocytes are well established. Little is known, however, of regulatory effects of thyroid hormone on interstitial proteins. In this study we examined the effects of thyroid hormone on collagen gene expression in thyroid hormone-induced myocardial hypertrophy and the response of cardiac fibroblasts to thyroid hormone in culture. Adult male Sprague-Dawley rats were treated intraperitoneally with L-thyroxin (10 pg/100 g body wt) for 2 hours or 1, 2, 3, 6, 12, or 14 days. Northern blot analysis of RNA from total ventricular tissue showed that after 2 hours of treatment, the abundance of mRNA for pro tv2 (I) collagen decreased by 53% (p<0.05) and reached the lowest level (60%o decrease, p<O.02) at day 1, remained diminished at day 3, and then gradually returned toward normal levels. After transient transfection of chimeric DNA containing collagen type I promoter-chloramphenicol acetyl transferase (CAT) gene into the thyroxin-treated cardiac fibroblasts, the level of CAT activity decreased significantly.
examined collagen gene expression in the rat model of myocardial hypertrophy induced by thyroid hormone and examined the response of cardiac fibroblasts to thyroid hormone in culture. The results provide insights into the mechanism of action of thyroid hormone with regards to myocardial collagen biosynthesis. They also provide information that although related to the heart tissue, may prove to be the reflection of the general regulatory role of thyroid hormone on collagen gene expression in various tissues.
Materials and Methods Animal Model
Adult male Sprague-Dawley rats (200-220 g) were maintained on standard rat chow diet with access to water and received daily injections (10 ,tg/100 g body wt i.p.) of L-thyroxin. A total of 100 rats were used for all steps involving initial studies for dose determination, blood pressure measurement, data collection, and immunofluorescent studies. All survived the full course of treatment. Rats were killed at an early stage (within hours) or over an extended period of 14 days after treatment (days 1, 2, 3, 6, or 12 for mRNA studies and day 14 for immunofluorescent light microscopy). Mean arterial pressure, body weight, and ventricular heart weight were measured at the end of each time point.
Preparation and Treatment of Cardiac Fibroblasts in Culture
Cardiac fibroblasts were prepared as previously described. 10 Briefly, adult male New Zealand White rabbits were anesthetized, and hearts were excised, minced, and washed in 1 x phosphate buffered saline (PBS). The tissue was then subjected to digestion at 35°C by a mixture of 0.1% trypsin and 200 IU/ml collagenase (type IV, Sigma) for 10 minutes by constant shaking in a 25 -ml glass Erlenmeyer flask. Isolated cells were pelleted at the end of 10-minute digestion periods and plated on 100-mm culture dishes in Dulbecco's Modified Eagle Medium (DMEM) supplemented with 10% fetal bovine serum (FBS) and were incubated with 90% 02+ 10% CO2 for 2 hours at 37°C in an incubator with a humidifier. The unattached cells were then discarded, and attached cells (mostly fibroblasts) were grown in DMEM plus 10% FBS. The fibroblastic nature of the cells was determined by immunofluorescence staining with anti-human factor VIII for detection of endothelial cells, anti-desmin for muscle cells, and anti-vimentin for fibroblasts, as previously described.10 Confluent cells were either passaged or stored. For all studies, cells from passages 4-9 were used. For drug treatment, cells were grown until confluent in DMEM plus 10% FBS on 100-or 60-mm culture dishes. They were then serum deprived (0.5-1%) for Six micrograms of plasmid DNA containing the 3.6 kb of upstream rat al(I) collagen promoter that was ligated into the Xba site of a chloramphenicol acetyl transferase (CAT) gene12 (generous gift of Dr. David Rowe) was mixed with 20 ,ug lipofectin (1 mg/ml solution; BRL, Gaithersburg, Md.) according to the manufacturer's guidelines and added to the cell medium. Before the addition of DNA-lipofectin complex, cell layers were washed with and maintained in serum-free medium. Twelve hours later, lipofectin was removed, and the cells were treated for 4-6 hours with medium containing 10% serum. Cells were then incubated for 48 hours in serum-free (0.5-1%) medium in the presence of 10 nM thyroxin. Control cells in identical conditions were transfected with equal amounts of plasmid DNA and received equal aliquots of vehicle (0.1N NaOH) instead of thyroxin. To examine nonspecific effect of thyroxin on promoter activity, parallel groups of cells were transiently transfected with 6 gg plasmid DNA containing SV40 promoter sequence linked to CAT reporter gene. Cells were treated under identical conditions as those that received a,(I) collagen promoter-CAT constructs.
Determination of the Activity of a,(I) Collagen Promoter
The activity of al(I) collagen and SV40 promoter in thyroxin-treated and control (untreated) cardiac fibroblasts was determined by measuring CAT enzyme activity according to Gorman et al.13 In each assay, aliquots of cell lysate containing equal amounts of protein from thyroxin-treated and control cells were assayed.
RNA Extraction
For studies of cardiac tissue, total RNA was extracted by the procedure of Chirgwin et al,14 with minor modifications as previously described.8 Briefly, hearts were rapidly dissected, atria removed, and ventricular myocardium homogenized in 4 M guanidine thiocyanate solution on ice. The homogenate was cleared of cell debris by centrifugation at 10,000g for 10 minutes. RNA was pelleted on a cesium chloride cushion and then redissolved in Tris-EDTA (pH 7.4) and purified by three ethanol precipitations. Total RNA was quantified by absorbance at 260 nm, assuming 40 gg/ml for each unit of absorbance.
For studies of cardiac fibroblasts, RNA was extracted from confluent cell layers in 100-mm culture dishes by modification of the method of Chomczynski and Sacchi. 15 Briefly, cell layers were washed twice with PBS, 4 M guanidine isothiocyate was added to the dishes, and cells were lysed by scraping and vortexing. Equal volumes of phenol (pH 7.4) were added to the cell lysate, and the mixture was centrifuged in a Sorvall centrifuge at 10,000g at 4°C for 20 minutes. The aqueous phase containing the RNA was then transferred to a fresh tube, and RNA was prepared by two steps of precipitation with 70% ethanol. probes to rat c-fos and rat c-jun20; and a 2.0-kb EcoRI fragment of the mouse early growth response gene (Egr-1) cDNA clone 0C68.21 After hybridization, the membranes were washed and exposed to Kodak XAR-5 film at -70°C. Prehybridization, hybridization, and washing procedures were performed according to the methods previously described.89
RNA-DNA Hybridization
Immunofluorescent staining. Cardiac fibroblasts were cultured in DMEM plus 10% FBS on Lab-Tek Permanox chamber slides or in 60-mm culture dishes (NUNC, Inc.) until confluent. They were then deprived of serum (0.5-1%) for 24 hours. L-Thyroxin (10 nM) was added to the culture over a 72-hour period. Control dishes received an equivalent volume of vehicle (0.1N NaOH). At the end of treatment, cell layers were washed twice with PBS and permeabilized in absolute methanol for 7 minutes at 4°C. For myocardial tissue studies, rats were treated for 14 days with L-thyroxin (10 ,g/100 g body wt). Preparation of frozen sections (12 ,um thick) was performed as previously described. 9 Staining of cell layers and tissue sections was performed as previously described.9 Briefly, samples were layered with 1:50 dilution of a rabbit anti-rat tail tendon type I collagen antibody,8'9 incubated at room temperature for 1 hour, and washed four times with PBS. Each wash lasted 2 minutes. As negative controls, parallel slides were incubated with immunoglobulin G (IgG) prepared from rabbit preimmune serum. Fluorescein isothiocyanate-conjugated goat anti-rabbit IgG was used as second antibody. Visualization was performed with an Olympus model BH2 epifluorescent microscope. Tri-X-400 film with 2 minutes' exposure time was used for photography.
[3H]Thymidine incorporation. Cardiac fibroblasts were grown until confluent in DMEM plus 10% FBS on 35-mm culture dishes. They were then serum deprived (0.5-1%) for 24 hours. L-Thyroxin (10 nM) was added to the culture medium for 22 hours.
[3H]Thymidine (5 ,uCi/ml) (specific activity, 86 Ci/mmol [Amersham]) was added to the medium. After 3 hours, cells were washed three times with PBS and lysed in 0.1% sodium dodecyl sulfate and 0.1 M NaOH. DNA was precipitated by 5% trichloroacetic acid. The precipitate was filtered, and then the filters were washed with 10% trichloroacetic acid and 95% ethanol. The radioactivity of the filters was determined by liquid scintillation counting.10 DNA was quantified by the use of chromogenic reagent (0.1 M acetaldehyde, 1.5% diphenylamine in glacial acetic acid, and concentrated sulfuric acid).
Quantification and Data Analysis mRNAs and promoter activity were quantified by densitometry scanning (Hoefer) of Northern and CAT assay autoradiographs, respectively. To determine CAT activity, the density of acetylated ['4C]chloramphenicol and untransformed chloramphenicol spots on the autoradiogram was measured. CAT activity was the percentage of acetylated ['4Clchloramphenicol in a 1-hour reaction. To determine the abundance of mRNA, ribosomal RNA bands on the gene screen membrane were visualized by ethidium bromide staining and photographed. The density of the 28S ribosomal RNA band was measured by densitometry scanning of the negatives. To obtain a precise measurement of mRNA per unit total RNA (i.e., normalized mRNA), the density of an individual mRNA band was divided by the density of the corresponding 28S ribosomal RNA band on the gene-screen membrane. To eliminate intergel density differences, all data are presented as a percent of the control value (normalized mRNA for treated group/ normalized mRNA for the corresponding control group). It should be noted that samples from a treated group and the corresponding controls were always run on a single gel.
As discussed above, the mRNA measurement, presented as a percent of control, represents the ratio of two means (i.e., treated group mean/control group mean). Standard error of this percent mRNA was computed from the standard errors of measured data using the principle of propagation of error. 22 The percent mRNA data at different times were compared with controls (i.e., 100%) by computing the t statistics, with the significance level adjusted for multiple comparisons by Bonferroni bounds.
Results

Blood Pressure and Heart Weight
Treatment of rats with L-thyroxin (10 ,g/100 g body wt) resulted in an increased mean arterial pressure that was statistically significant after 6 days of treatment ( Figure 1 ). The induction of myocardial hypertrophy was examined by comparing the ratio of total ventricular weight to the body weight in thyroxin-treated and control rats over 12 days of treatment (Figure 1 ). In the treated group this ratio began to increase from day 1, and at day 6 it was increased by 13% (p<0.01). The increase in the ratio of ventricular weight to body weight was caused by the increased ventricular weight and not the reduced body weight values (Figure 1 Thyroxin treatment of cardiac fibroblasts also led to the induction of an early response. mRNAs for proto- Bd 12d TME FIGURE 3 . Results of densitometry scanning of autoradiograms from Northern hybridization analysis of total RNA from ventricular myocardium of rats treated with l -thyroxin and control age-matched rats. RNA (10 pg) from treated and untreated ventricular tissues was applied to 1% agarose gel Electrophoresis and blotting were performed as described in "Materials and Methods." Blots were hybridized to 32p_ labeled cDNA probes to rat pro a2(I) collagen, human transforming growth factor-,f1 (TGF-f31), and chicken /3-actin. Densitometry scanning was performed to measure the density of mRNA and the corresponding 28S ribosomal RNA bands as described in "Materials and Methods." Data are expressed as means ofthree individual experiments. *p<a.OS, **p<002, ***P<0.01, ****p<0o001. oncogenes c-fos, c-jun, and Egr-1 were induced in cardiac fibroblasts as early as 30 minutes after the addition of thyroxin to the culture medium ( Figure 4 ).
Effect of Thyroid Hormone on Collagen Type I Promoter Activity
Transient transfection of chimeric DNA that contained 3.6 kb upstream al(I) collagen promoter linked to CAT gene into the cardiac fibroblasts showed that treatment of the cells with thyroxin after the transfection led to significant decrease in CAT activity in treated compared with untreated cells ( Figure 5) not increase, and the patterns of immunofluorescent staining in treated hearts were somewhat similar to those in untreated hearts ( Figure 7 ). In cardiac fibroblasts, immunofluorescent staining of thyroxin-treated cells was diminished compared with that of untreated cells ( Figure 7 ). It is also noteworthy that the morphology of treated cells as examined by phase contrast light microscopy showed no apparent differences with those of untreated cells. (Figure 8) . Discussion Influence of thyroid hormone on cardiac myocytes and myocyte-specific proteins, such as a-and ,B-myosin heavy chain, has been extensively investigated. Little is known, however, about the effect of thyroid hormone on expression of collagen gene in the myocardium and the responsiveness of interstitial cells to this hormone. Our findings have several significant aspects. 1) Abundance of mRNA for collagen type I, the major fibrillar collagen of the heart, is downregulated by thyroid hormone both in the myocardium and in cardiac fibroblasts in culture. 
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